GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC

Virginia Cancer Institute, Richmond

Florida Hosptial Cancer Center- AdventHealth, Orlando

Norton Healthcare Cancer Institute, Louisville

Orchard Healthcare, Skokie

Robert H Lurie Cancer Center at Northwestern University, Chicago

University of Illinois at Chicago, Chicago

East Jefferson General Hospital, Metairie

Ocshner Cancer Institute, New Orleans

University of Colorado Cancer Center, Aurora

St Joseph Hospital of Orange, Orange

Dartmouth Hitchcock Medical Center, Lebanon